Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)
Open Access
- 1 December 1996
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 271 (52), 33647-33653
- https://doi.org/10.1074/jbc.271.52.33647
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Local Infusion of FGF-Saporin Reduces Intimal HyperplasiaJournal of Surgical Research, 1996
- Heparan sulfate fibroblast growth factor receptor complex: Structure‐function relationshipsMolecular Reproduction and Development, 1994
- Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxinCancer, 1994
- Fibroblast growth factor-2 (FGF-2) in the nucleus: Translocation process and targetsBiochemical Pharmacology, 1994
- Reducing the Heterogeneity of Chemically Conjugated Targeted Toxins: Homogeneous Basic FGF-SaporinAnalytical Biochemistry, 1993
- Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast DifferentiationScience, 1991
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorCell, 1991
- Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycanJournal of Cellular Physiology, 1989
- Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.The Journal of cell biology, 1988